Brief: Iteos Therapeutics Inc - Cash And Investment Balance Of $731.4Mm As Of December 31, 2022, Expected To Provide Runway Into 2026
March 15 (Reuters) - Iteos Therapeutics Inc ITOS.O :
* ITEOS THERAPEUTICS INC - CASH AND INVESTMENT BALANCE OF
$731.4MM
AS OF DECEMBER 31, 2022, EXPECTED TO PROVIDE RUNWAY INTO 2026
* ITEOS THERAPEUTICS INC - EOS-984 EXPECTED TO ENTER
CLINICAL
STUDIES IN MID-2023
* ITEOS THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
INVESTMENTS
POSITION WAS $731.4 MILLION AS OF DECEMBER 31, 2022
* ITEOS THERAPEUTICS INC- QTRLY NET INCOME ATTRIBUTABLE TO
COMMON
SHAREHOLDERS WAS $20.5 MILLION, OR A NET INCOME OF $0.54 OF PER
DILUTED SHARE
Source text for Eikon: ID:nGNEkDGnW
Further company coverage: ITOS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on iTeos Therapeutics
See all newsIteos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Iteos Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview
Brief: Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
U.S. STOCKS ON THE MOVE-Nvidia, Salesforce, Kestrel Group
U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Sonic Automotive